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INTRODUCTION 
Chewing gums are taken orally and oral route of drug 
delivery is the most preferred route amongst the patient and 
clinicians due to various advantages it offers, in recent years 
chewing gums are considered to be friendly oral mucosal 
drug delivery systems1. Chewing gum has been used to 
deliver therapeutic agents such as nicotine for smoking 
cessation therapy. A medicated chewing gum is solid, 
single-dose preparation that is intended to be chewed for a 
certain period of time, deliver the drug and which may 
contain one or more than one active pharmaceutical 
ingredient2. Chewing gums are not swallowed and the 
remaining mass after chewing is discarded. During chewing 
the drug contained in the gum is released into the saliva. 
The released drug has got two fates; either it could be 
absorbed through the oral mucosa or may reach the stomach 
for GI absorption. In fact both these two fates may occur 
simultaneously. So, medicated chewing gums offer both 
local and systemic effect4. This drug delivery system offers 
two absorption pathways. Drug absorbed directly via the 
buccal membrane avoids metabolism in the gastrointestinal 
tract and thus the chance of first pass effect of the liver. As 
a result drug formulation as medicated chewing gum may 
require reduced dose compared to other oral drug delivery 
systems5. 
ADVANTAGES OR DISADVANTAGES
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Advantages: 
1. Convenient – promoting higher compliance. 
2. Discreet- less stigmatization. 
3. Administration without water can be taken anywhere. 
4. Excellent for acute medication. 
5. Advantageous for patients with difficulty in 
swallowing tablets. 
6. Pleasant taste. 
7. Counteracts dry mouth: Through stimulation of the 
salivary secretion thereby preventing. 
8. Candidacies and caries. 
9. Highly acceptable by children. 
10. The active compounds absorbed at oral level avoid the 
hepatic circulation and the associated metabolism. 
11. The product is rapidly released from the gum after a 
short period mastication; some absorption takes place 
by directly through the oral mucosa depending on the 
active ingredient. Importantly not being swallowed the 
gum does not reach the stomach. Moreover, the 
stomach does not suffer from direct contact with high 
concentrations of active principle, thus reducing the 
risk of intolerance of the gastric mucosa. 
12. The fraction of product reaching the stomach is 
conveyed by the saliva and delivered continuously and 
regularly. Active substances are released from medical 
chewing gum during chewing and are dissolved in 
saliva. The release rate can be carefully controlled 
through the formulation of the chewing gum allowing 
extended exposure in the oral cavity. Active 
substances that are absorbed through the buccal 
mucosa pass via the jugular veins directly into the 
systemic circulation. Due to the rich vascular supply of 
the buccal mucosa, measurable concentrations of 
active substances may be in the blood after only a few 
minutes of chewing and fast onset of action is thus 
likely to be attained. Furthermore, bioavailability may 
be increased, as hepatic first pass metabolism and 
gastrointestinal tract degradation are tract degradation 
are avoided for buccal-absorbed substances. 
13. Consequently, a lower dosage of substance may be 
therapeutically sufficient, possibly resulting in a fewer 
side effects, and promote fast absorption. Active 
substances released from chewing gum are dissolved 
in saliva when swallowed and are, therefore, readily 
accessible for absorption in the gastrointestinal tract. 
Disadvantages 
1. Risk of over dosage with MCG compared with 
chewable tablets or lozenges that can be consumed in a 
considerable. 
2. Number and within much shorter period of time. 
ABSTRACT 
Chewing gums are mobile drug delivery systems. It is a potentially useful means of administering drugs either locally or 
systemically via, the oral cavity. Several ingredients are now incorporated in medicated chewing gum, e.g. Fluoride for 
prophylaxis of dental caries, chlorhexidine as local disinfectant, nicotine for smoking cessation, aspirin as an analgesic, and 
caffeine as a stay alert preparation. It was concluded that chewing gum is an excellent drug delivery system for self-
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which are released by chewing and are intended to be used for local treatment of mouth diseases or systemic delivery after 
absorption through the buccal mucosa. 
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3. Sorbitol present in MCG formulation may cause 
flatulence, diarrhea. 
4. Additives in gum like flavouring agent, Cinnamon can 
cause Ulcers in oral cavity and Licorice cause 
Hypertension. 
5. Chlorhexidine oromucosal application is limited to 
short term use because of its unpleasant taste and 
staining properties to teeth and tongue. 
6. Chewing gum has been shown to adhere to different 
degrees to enamel dentures and fillers. 
7. Prolong chewing on gum may result in pain in facial 
muscles and earache in children. 
MECHANISM OF DRUG TRANSPORT  
During the chewing process, most of the medications 
contained within the drug product are released into the 
saliva and are either absorbed through buccal mucosa or 
swallowed or absorbed through GIT. 
Major pathways of drug transport across buccal mucosa 
follow simple fickian diffusion. Passive diffusion occurs in 
accordance without the pH partition theory. Some carrier 
mediated transport also observed. Equation for drug flux is: 
J = DKp/ΔCe 
Where, 
J = drug flux 
D = diffusivity 
Kp = partition coefficient 
ΔCe = concentration gradient 
h = diffusional path length 
It shows (h) that the flux may be increased by decreasing 
the diffusional resistance of the membrane by making it 
more fluid, increasing the solubility of the drug in the saliva 
immediately adjacent to the epithelium or enhancing the 
lipophilicity through pro-drug modification. Because of the 
barrier properties of the tight buccal mucosa, the rate 
limiting step is the movement of the drug molecules across 
the epithelium. 
Two pathways of permeation across the buccal mucosa are 
transcellular and paracellular. Permeability coefficient 
typically ranges from 1x10-5 to 2x10-10 cm/s. The pathway 
of drug transport across oral mucosa may be studied using: 
 Microscopic techniques using fluorescent dyes 
 Autoradiography and 
 Confocal laser scanning microscopic procedures.
 
 
Figure 1: Routes and Mechanisms for Drug Transport across Epithelia9 
MANUFACTURING PROCEDURE
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Different methods can be employed for the manufacturing 
of Chewing Gum; however, these can be broadly 
classified into three main classes namely: 
1. Conventional/ traditional Method (Melting). 
2. Cooling, grinding and tabletting Method. 
3. Direct Compression Method 
1. Conventional/ traditional Method:
 
Components of gum base are softened or melted and 
placed in a kettle mixer to which sweeteners, syrups, 
active ingredients and other excipients are added at a 
definite time. The gum is then sent through a series of 
rollers that forms into a thin, wide ribbon. During this 
process, a light coating of finely powdered sugar or sugar 
substitutes is added to keep the gum away from sticking 
and to enhance the flavor. In a carefully controlled room, 
the gum is cooled for upto 48 hours. This allows the gum 
to set properly. Finally the gum is cut to the desired size 
and cooled at a carefully controlled temperature and 
humidity. However, the conventional method has number 
of limitations like elevated temperature used in melting, 
restricts the use of this method for thermo labile drugs. 
Controlling of accuracy and uniformity of drug dose 
becomes difficult due to melting and mixing of highly 
viscous gum mass makes. Such a chewing gum 
composition is difficult to form into chewing gum tablets 
because of their moisture content (2-8%). If attempted to 
grind and tablet such a composition would jam the 
grinding machine, stick to blades, screens adhere to 
punches and would be difficult to compress. Technology 
not so easily adaptable to incorporate the stringent 
manufacturing conditions required for production of 
pharmaceutical products12. 
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COMPOSITION
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Table 1: Represent Composition of medicated chwing gum. 
Component  Function  Example  
Water insoluble 
gum base  
  
Elastomers  Provides elasticity and  
controls gummy texture  
Natural (chicle gum, nispero, rosadinha, jelutong, periollo, 
lechi-capsi, sorva etc.) and synthetic rubbers (butadiene, 
styrene copolymers, polyisobutylene, polyethylene 
mixtures, polyvinyl alcohol etc.)  
Elastomer 
solvents  
Softening the elastomer base component  Terpinene resins (polymers of alpha-pinene or beta-
pinene), modified resins or gums (hydrogenated, dimerized 
or polymerized resins)  
Plastisizers To obtain a variety of desirable textures 
and consistency proper-ties  
Lanolin, palmitic acid, oleic acid, stearic acid, glyceryl 
triacetate, propylene glycol monostearate, glycerine, 
natural and synthetic waxes, hydrogenated vegetable oils, 
paraffin waxes, fatty waxes, sorbitalmonostearate, 
propylene glycol  
Fillers or 
texturizers or  
mineral adjuvant  
Provide texture, improve chewability, 
provide reasonable size of the gum lump 
with low dose drug  
Calcium carbonate, magnesium carbonate, aluminum 
hydroxide, talc, aluminum silicate  
Water soluble 
portions  
  
Softners and 
emulsifiers  
These are added to the chewing gum in 
order to optimize the chewability and 
mouth feel of the gum  
Glycerin, lecithin, tallow, hydrogenated tallow, mono/ di/ 
tri glycerides  
Colorants and 
whiteners  
Gives the formulation soothing color and 
improves acceptability of the formulation  
Titanium dioxide, natural food colors and dyes suit-able 
for food, drug and cosmetic applications  
Sweeteners  To provide the desired sweetness of the 
product  
Water soluble sweetening agents (xylose, ribulose, 
glucose, mannose, galactose, sucrose, fructose, mal-tose, 
monellin, sugar alcohols like sorbitol, mannitol etc.), water 
soluble artificial sweeteners (sodium or calcium saccharin 
salts, cyclamate salts etc.), di-peptide based sweeteners 
(aspartame, alitame etc.), naturally occurring water soluble 
sweeteners, chlo-rinated derivatives of ordinary sugar 
(sucralose), protein based sweeteners (thaumatin I and II)  
Antioxidants  Prevents any possible microbial growth  Butylatedhydroxytoluene, butylatedhydroxyanisole, propyl 
gallate 
Flavoring agents  To enhance consumer acceptability Essential oils (citrus oil, fruit essences, peppermint oil, 
spearmint oil, mint oil, clove oil and oil of wintergreen) 
and synthetic or artificial flavors  
Bulking agents  Used if low calorie gum is desired  Polydextrose, oligofructose, inulin, fructooligosaccharides, 
guargumhydrolysate, indigestible dextrin  
Compression 
adjuvant  
To ease the compression process  Silicon dioxide, magnesium stearate, calcium stearate, talc  
 
2. Cooling, Grinding and Tableting Method: 
This method has been developed with an attempt to lower 
the moisture content and alleviate the problems faced in 
conventional method. The Chewing Gum composition 
(base) is cooled to a temperature at which the composition 
is sufficiently brittle and would remain brittle during the 
subsequent grinding step without adhesion to the grinding 
apparatus. The temperature required for cooling is 
determined in part by the composition of the Chewing 
Gum and is easily determined empirically by observing 
the properties of the cooled chewing gum composition. 
Generally the temperature of the refrigerated mixture is 
around -15oC or lower. Amongst the various coolants like 
liquid nitrogen, hydrocarbon slush use of solid carbon 
dioxide is preferred as it can give temperatures as low as 
78.50C. The solid carbon dioxide sublimes readily on 
warming the mixture and is not absorbed by the chewing 
gum composition. It does not interact adversely with the 
processing apparatus and does not leave behind any 
residue which may be undesirable or potentially 
hazardous. The refrigerated composition is then crushed 
or ground to obtain minute fragments of finely ground 
pieces of the composition. Alternatively, the steps of 
cooling the chewing gum composition can be combined 
into a single step. The grinding apparatus itself is cooled 
by keeping the grinding apparatus in contact with a 
coolant or by placing the grinding apparatus in a cooling 
jacket of liquid nitrogen or other cold liquid. For more 
efficient cooling, the chewing gum composition can be pre 
cooled prior to cooling to the refrigeration temperature2. 
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Sometimes a mixture of chewing gum composition, solid 
carbon dioxide and precipitated silica is ground in a mill 
grinder in a first grinding step. Additional solid carbon 
dioxide and silica are added to the ground composition, 
and the composition is further ground in a second grinding 
step. This two step grinding process advantageously keeps 
the chewing gum composition at a very low temperature. 
The presence of solid carbon dioxide also serves to 
enhance the efficiency of the grinding process. The same 
process can be made multiple by incorporating additional 
carbon dioxide and/or precipitated silica at each step. 
Certain additives can be added to the chewing gum 
composition to facilitate cooling, grinding and to achieve 
desired properties of chewing gum. These include use of 
anti-caking agent and grinding agent12. 
Once the coolant has been removed from the powder, the 
powder can be mixed with other ingredients such as 
binders, lubricants, coating agents, sweeteners, etc. all of 
which are compatible with the components of the chewing 
gum base in a suitable blender such as sigma mill or a 
high shear mixer. 
Alternatively a Fluidized Bed Reactor (FBR) can also be 
used. The use of FBR is advantageous as it partially 
rebuilds the powder into granules, as well as coats the 
powder particles or granules with a coating agent thereby 
minimizing undesirable particle agglomeration. The 
granules so obtained can be mixed with anti adherents like 
talc. The mixture can be blended in a V type blender, 
screened & staged for compression. Compression can be 
carried out by any conventional process like punching15. 
Cooling, Grinding and Tabletting Method thus overcomes 
the limitations of Conventional technique. However, it 
requires equipment other than conventional tabletting 
equipment thus making it expensive process as compared 
to Conventional process. Similar to the Conventional 
process even this process requires careful monitoring of 
humidity during the tabletting process. 
3. Direct Compression Chewing Gum: 
SPI pharma has developed a compatible gum system 
known as Pharmagum. Pharmagum is a mixture of polyols 
and of sugar with gum base. Pharmagum® S consists 
primarily of gum base and sorbitol. Pharmagum® M 
contains gum base, Mannitol and Isomalt. These are free 
flowing powders, which are directly compressible. The 
gum is manufactured under CGMP conditions and 
complies with food chemicals. Direct compression 
chewing gum can be directly compressed on a traditional 
tabletting machine, thus enabling rapid and low cost 
development of a gum delivery system13. 
EVALUATION TESTES
21 
As per specifications given in European Pharmacopoeia: 
1) Test for Uniformity of Content: Unless otherwise 
prescribed or justified and authorized medicated chewing 
gum with content of 2 mg or less than 2 percent of the 
total mass of gum comply with test. 
2) Uniformity of mass: Uncoated medicated chewing 
gum and unless otherwise justified and authorized coated 
medicated chewing gum comply with the test for 
uniformity of mass of single- dose preparations. 
3) Drug release from medicated chewing gum: It has 
been reported commercially that the drug release from 
medicated chewing gum as per the specification given in 
European Pharmacopoeia and is determined by applying a 
mechanical kneading procedure to a piece of gum placed 
in a small chewing chamber containing a known volume 
of buffer solution. 
Factor effecting release of drug ingredients 
1. Contact Time: 
The local or systemic effect is dependent on time of 
contact of Medicated Chewing Gum in oral cavity. In 
clinical trial chewing time of 30 minutes was considered 
close to ordinary use. The average chewing rate is about 
60 chews every minute17. 
2. Physicochemical properties of active ingredient: 
Physicochemical properties of active ingredient plays very 
important role in release of drug from Medicated Chewing 
Gum. The saliva soluble ingredients will be immediately 
released within few minutes whereas lipid soluble drugs 
are released first into the gum base and then released 
slowly. Release of water soluble drug (aqueous solubility 
greater than 1:10) is, in general, about 75% or more 
during 5 min. of chewing and 90% or more during 15 min. 
of chewing at rate of 60 chews per minute. Drugs with 
aqueous solubility between 1:10 and 1:300 demonstrate up 
to 60% release during 10 minutes of chewing and between 
50 to 90% when the gum is chewed for 15 min. The 
release of the drug, which is only slightly water-soluble, 
can only be expected to be small (less than 5%) even if the 
gum is chewed for 30 min18. 
3. Inter individual variability: 
The chewing frequency and chewing intensity which 
affect the drug release from Medicated Chewing Gum 
may vary from person to person. In-vitro study prescribed 
by European Pharmacopoeia suggest 60 cycles per minute 
chewing rate for proper release of active ingredient19. 
4. Formulation factor: 
Composition and amount of gum base affect rate of 
release of active ingredient. If lipophilic fraction of gum is 
increased, the release rate is decreased19.The influence of 
gum base mass on drug release has been investigated 
using salicylamide as model drug. When salicylamide was 
incorporated into a chewing gum, which contained a 
relatively large percentage of gum bases, the release after 
30 min. of chewing was significantly lower (25.6%) 
compared to a gum in which less gum base was present 
(52%)20. 
APPLICATIONS OF MCGS 
1. Local therapy:  
Prevention and cure of oral diseases are obvious targets 
for chewing gum formulations. Chewing gum can release 
an active substance at a controlled rate over an extended 
period of time providing a prolonged local effect. Sugar-
free chewing gum is known to be beneficial to dental 
health. It has been shown that use of sugar-free chewing 
gum after meals re elevates plaque pH21, 22. Low plaque 
pH plays an important role in the development of dental 
caries. Therefore, in caries prevention programmes, 
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sugar-free chewing gum is recommended after meals and 
snacks as a supplement to tooth brushing28. 
Indications for fluoride chewing gum are prevention of 
dental carries in children in fluoride-deficient areas, in 
adults with a high incidence of caries, and in patients with 
xerostomia. The caries-preventive effect of fluoride 
chewing gum has been compared with the effect of 
placebo chewing gum in experiments with artificial 
enamel lesions on teeth mounted into removable 
mandibular appliances worn in situ in volunteers for 
several days. The remineralization process proved to be 
faster when using the fluoride chewing gum.  
Oral infections caused by bacteria or fungi are often seen, 
especially in patients with impaired immune system. 
Chlorhexidine chewing gum can be used for alleviation of 
gingivitis, periodontitis, and other oral and pharyngial 
infections. It can also be used for inhibition of plaque 
growth and has proven valuable in oral health care of the 
elderly. Furthermore, chlorhexidine in a chewing gum 
formulation gives less staining of the teeth and is more 
convenient to use than a chlorhexidine mouth rinse. The 
chlorhexidine released by chewing is distributed evenly in 
the oral cavity and is present there for a prolonged period 
of time. The bitter taste of chlorhexidine can be masked 
quite well in a chewing gum formulation Clinical trials 
involving patients with oral candidosis have shown that 
miconazole chewing gum is at least as efficient as 
miconazole oral gel in the treatment of fungal infections in 
the mouth. Furthermore, patients preferred chewing gum 
to oral gel due to convenience and fewer side effects. A 
miconazole chewing gum is yet to be launched29.  
2. Systemic Therapy:  
Chewing gum as a drug delivery system also provides 
benefits to systemic drug delivery, especially if the active 
substance is absorbed through the buccal mucosa. From a 
patient point of view, a number of benefits appear: Fast 
and acute treatment, convenience, no need for water and 
thereby easy administration anytime anywhere reduced 
risk of gastrointestinal side effects, and no attention 
drawn to the condition requiring medication. These 
benefits apply not only to the treatment of adults, but also 
to the treatment of children and adolescents. Chewing 
gum as a drug delivery system could be beneficial to a 
number of indications, some of which are discussed 
below30.  
 Pain:  
Successful treatment of minor pains, headaches, pains of 
cold, muscular aches, etc. requires rapid absorption of 
therapeutic doses of the active substance. Chewing gum 
as a drug delivery system could be beneficial in minor 
pain treatment, when buccal absorption results in fast 
onset of action and reduces the risk of gastrointestinal 
side effects. The bioavailability of acetylsalicylic acid in 
a chewing gum formulation relative to an unbuffered 
tablet formulation has been determined. Absorption from 
the chewing gum formulation was shown to be faster than 
absorption from the tablet, and consequently, a chewing 
gum formulation may provide faster pain relief. A 
chewing gum formulation may also be useful in the 
treatment of acute, strong pain. Bioavailability of 
methadone from a chewing gum formulation has been 
compared to a tablet formulation. There was no 
significant difference in the bioavailability of the two 
formulations 26. The substance abuse problem with 
methadone tablets could be considerably reduced by 
formulating methadone in a chewing gum, as the active 
substance can only be released by chewing29.  
 Smoking Cessation:  
Chewing gum formulations containing nicotine, lobeline 
and silver acetate have been clinically tested as aids to 
smoking cessation. A comparison of success rates and 
adverse reactions showed that nicotine was superior to 
the other two substances 27, 28, 29. Several clinical 
studies have proven the efficacy of nicotine chewing gum 
as an aid to smoking cessation. Nicotine chewing gum 
can be regarded as a convenient formulation for breaking 
an "oral habit" like smoking as the "oral habit" of 
smoking is substituted by another oral activity, namely 
gum chewing. The cessation rates observed after one year 
of treatment vary from 13-63% in various clinical trials 
involving nicotine chewing gum, whereas the cessation 
rate using placebo chewing gum ranges from 9-45%. 
 Obesity:  
Several chewing gum formulations containing caffeine, 
guarana or chromium are available. Caffeine and guarana 
are central stimulating anorectic agents that have proved 
to increase the metabolic rate. Moreover, they stimulate 
lipolysis, have a thermogenic effect (increase energy 
expenditure) and reduce the feeling of hunger. Chromium 
is claimed to reduce the craving for food due to an 
improved blood glucose balance. However, none of the 
existing products are registered as pharmaceutical 
products with a documented and approved effect on 
obesity. Chewing gum has proven efficient in treatments 
involving instant craving and „oral habits‟. Hence there is 
a rationale for administering weight reducing active 
substances in a chewing gum formulation.  
3. Therapeutic Uses of MCGS19 
Table 2: Represent Therapeutic uses of Medicated 
Chewing gum. 
 
 
 
 
Therapeutic use  Specific example  
Oral antifungal  Econazole, Nystatine, 
Miconazole 
Smoking cessation  Nicotine, Silver acetate  
Pain relievers  Aspirin, Methadone  
CNS stimulation, 
improvement of memory  
Caffeine  
Treatment of otitis media  Xylitol  
Treatment of dental carries  Chlorhexidine 
Treatment of vitamin C 
deficiency  
Dimenhydrinate 
Treatment and management 
of motion sickness  
Antacid  
Acid neutralization  Antacid  
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FUTURE TRENDS
20, 30
 
Chewing gum not only offers clinical benefits but also is 
an attractive, discrete and efficient drug delivery system. 
A few decades ago, the only treatment for some disease 
was surgical procedure but now more and more disease 
can be treated with Novel Drug Delivery Systems. 
Generally, it takes time for a new drug delivery system to 
establish itself in the market and gain acceptance by 
patients, however chewing gum is believed to manifest its 
position as a convenient and advantageous drug delivery 
system as it meets the high quality standards of 
pharmaceutical industry and can be formulated to obtain 
different release profiles of active substances. 
The potential of MCG for buccal delivery, fast onset of 
action and the opportunity for product line extension 
makes it an attractive delivery form. Reformulation of an 
existing product is required for patent protection, 
additional patient benefits and conservation of revenues. 
CONCLUSION 
In the future, we may see drugs formulated into chewing 
gum in preference to other delivery systems to deliver 
drugs locally to the oral cavity. The reason is simple that 
the chewing gum delivery system is convenient, easy to 
administer anywhere, anytime and its pleasant taste 
improves patient compliance. Thus, it can be concluded 
that the chewing gum can be used, as a carrier for vast 
categories of drugs where extended release and the local 
action is desired. Chewing gum can be used without 
water, at any time.   
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